{"transactions":[{"id":691810,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-08-10T10:07:10.000Z","date":"2026-08-07","kind":"purchase","planned":false,"acquired":true,"shares":23900,"price":20.85,"value":498315.0,"ownership":{"direct":false,"nature":"The Larry Wood Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.67 to $21.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":23900,"source":{"system":"sec-edgar","filing":"0001628280-26-054970","document":"wk-form4_1786356427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828026054970/wk-form4_1786356427.xml","form_type":"4"}},{"id":853409,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-09T21:45:06.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":103653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date."}],"balance_after":103653,"derivative":{"exercise_price":25.35,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":103653},"source":{"system":"sec-edgar","filing":"0001628280-26-016156","document":"wk-form4_1773092704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828026016156/wk-form4_1773092704.xml","form_type":"4"}},{"id":853408,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-09T21:45:06.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":127783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth\nof the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":313378,"source":{"system":"sec-edgar","filing":"0001628280-26-016156","document":"wk-form4_1773092704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828026016156/wk-form4_1773092704.xml","form_type":"4"}},{"id":1047799,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-04T21:39:56.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":319618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option was granted on September 2, 2025 and one-quarter of the shares subject to the Stock Option will vest on September 2, 2026, and the remainder shall vest monthly thereafter at the rate of 1/48th of the original number of shares subject to the Stock Option, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":319618,"derivative":{"exercise_price":39.57,"expiration_date":"2036-09-01","underlying":"Common Stock","underlying_shares":319618},"source":{"system":"sec-edgar","filing":"0001440660-25-000004","document":"wk-form4_1757021993.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000144066025000004/wk-form4_1757021993.xml","form_type":"4"}},{"id":1047798,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-04T21:39:56.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":182392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on September 2, 2026, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The ending balance was adjusted to reflect the forfeiture (for no consideration) of 2,765 unvested RSUs previously granted to the Reporting Person in April 2024 and June 2025 under the issuer's non-employee director compensation program."}],"balance_after":185595,"source":{"system":"sec-edgar","filing":"0001440660-25-000004","document":"wk-form4_1757021993.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000144066025000004/wk-form4_1757021993.xml","form_type":"4"}},{"id":1064503,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-08-18T22:11:18.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":false,"shares":8950,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35800,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":8950},"source":{"system":"sec-edgar","filing":"0001225208-25-007321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825007321/doc4.xml","form_type":"4"}},{"id":1064502,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-08-18T22:11:18.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":8950,"price":78.0647,"value":698679.065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.68 to $78.43. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":206900.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-007321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825007321/doc4.xml","form_type":"4"}},{"id":1064501,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-08-18T22:11:18.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":true,"shares":8950,"price":59.2567,"value":530347.465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."}],"balance_after":215850.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-007321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825007321/doc4.xml","form_type":"4"}},{"id":1110320,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-06-16T21:09:27.000Z","date":"2025-06-16","kind":"exercise","planned":true,"acquired":false,"shares":8950,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44750,"derivative":{"exercise_price":59.2567,"exercise_date":"2020-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":8950},"source":{"system":"sec-edgar","filing":"0001225208-25-005981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005981/doc4.xml","form_type":"4"}},{"id":1110319,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-06-16T21:09:27.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":8950,"price":75.2255,"value":673268.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $74.8901 to $75.4400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":206900.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-005981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005981/doc4.xml","form_type":"4"}},{"id":1110318,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-06-16T21:09:27.000Z","date":"2025-06-16","kind":"exercise","planned":true,"acquired":true,"shares":8950,"price":59.2567,"value":530347.465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."}],"balance_after":215850.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-005981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005981/doc4.xml","form_type":"4"}},{"id":1113217,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:25:53.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":2771,"derivative":{"exercise_price":64.23,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001628280-25-030987","document":"wk-form4_1749759946.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828025030987/wk-form4_1749759946.xml","form_type":"4"}},{"id":1113216,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:25:53.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":1538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":5968,"source":{"system":"sec-edgar","filing":"0001628280-25-030987","document":"wk-form4_1749759946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828025030987/wk-form4_1749759946.xml","form_type":"4"}},{"id":1152752,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-05-12T23:30:30.000Z","date":"2025-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":988,"price":73.68,"value":72795.84,"ownership":{"direct":true},"balance_after":206900.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-004995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004995/doc4.xml","form_type":"4"}},{"id":1154302,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Performance Rights","published_at":"2025-05-09T23:34:09.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":11050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":11050,"derivative":{"exercise_date":"2028-05-08","underlying":"Common Stock","underlying_shares":11050},"source":{"system":"sec-edgar","filing":"0001225208-25-004940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004940/doc4.xml","form_type":"4"}},{"id":1154301,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:34:09.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":62000,"derivative":{"exercise_price":74.63,"exercise_date":"2026-05-08","expiration_date":"2032-05-07","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001225208-25-004940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004940/doc4.xml","form_type":"4"}},{"id":1154300,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:09.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":11050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":207888.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-004940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004940/doc4.xml","form_type":"4"}},{"id":1154299,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:09.000Z","date":"2025-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":819,"price":74.92,"value":61359.48,"ownership":{"direct":true},"balance_after":196838.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-004940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004940/doc4.xml","form_type":"4"}},{"id":1159952,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-05-05T23:29:30.000Z","date":"2025-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":410,"price":75.65,"value":31016.5,"ownership":{"direct":true},"balance_after":197657.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-004768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004768/doc4.xml","form_type":"4"}},{"id":1159951,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-05-05T23:29:30.000Z","date":"2025-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":396,"price":75.65,"value":29957.4,"ownership":{"direct":true},"balance_after":198067.3913,"source":{"system":"sec-edgar","filing":"0001225208-25-004768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004768/doc4.xml","form_type":"4"}},{"id":1264863,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2025-02-18T23:18:43.000Z","date":"2025-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":333,"price":76.19,"value":25371.27,"ownership":{"direct":true},"balance_after":198192.739,"source":{"system":"sec-edgar","filing":"0001225208-25-001907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001907/doc4.xml","form_type":"4"}},{"id":1376108,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2024-11-05T22:07:01.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":65.9145,"value":1647862.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $65.54 to $66.27. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":198525.739,"source":{"system":"sec-edgar","filing":"0001225208-24-009655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824009655/doc4.xml","form_type":"4"}},{"id":1488295,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:27:26.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":2526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option was granted on June 4, 2024 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":2526,"derivative":{"exercise_price":67.29,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":2526},"source":{"system":"sec-edgar","filing":"0001628280-24-027045","document":"wk-form4_1717705635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828024027045/wk-form4_1717705635.xml","form_type":"4"}},{"id":1488294,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:27:26.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":1376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":4430,"source":{"system":"sec-edgar","filing":"0001628280-24-027045","document":"wk-form4_1717705635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828024027045/wk-form4_1717705635.xml","form_type":"4"}},{"id":1519596,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2024-05-13T21:47:07.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":985,"price":86.72,"value":85419.2,"ownership":{"direct":true},"balance_after":223525.739,"source":{"system":"sec-edgar","filing":"0001225208-24-005984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005984/doc4.xml","form_type":"4"}},{"id":1522390,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Performance Rights","published_at":"2024-05-09T23:39:15.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":8725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":8725,"derivative":{"exercise_date":"2027-05-07","underlying":"Common Stock","underlying_shares":8725},"source":{"system":"sec-edgar","filing":"0001225208-24-005887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005887/doc4.xml","form_type":"4"}},{"id":1522389,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:39:15.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":51700,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001225208-24-005887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005887/doc4.xml","form_type":"4"}},{"id":1522388,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2024-05-09T23:39:15.000Z","date":"2024-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":695,"price":85.09,"value":59137.55,"ownership":{"direct":true},"balance_after":224510.739,"source":{"system":"sec-edgar","filing":"0001225208-24-005887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005887/doc4.xml","form_type":"4"}},{"id":1522387,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2024-05-09T23:39:15.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":8725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":225205.739,"source":{"system":"sec-edgar","filing":"0001225208-24-005887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005887/doc4.xml","form_type":"4"}},{"id":1526670,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Performance Rights","published_at":"2024-05-06T23:17:58.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":6675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":6675},"source":{"system":"sec-edgar","filing":"0001225208-24-005703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005703/doc4.xml","form_type":"4"}},{"id":1526669,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2024-05-06T23:17:58.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3541,"price":85.25,"value":301870.25,"ownership":{"direct":true},"balance_after":216480.739,"source":{"system":"sec-edgar","filing":"0001225208-24-005703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005703/doc4.xml","form_type":"4"}},{"id":1526668,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2024-05-06T23:17:58.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":6675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":220021.739,"source":{"system":"sec-edgar","filing":"0001225208-24-005703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005703/doc4.xml","form_type":"4"}},{"id":1526667,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2024-05-06T23:17:58.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":395,"price":85.06,"value":33598.7,"ownership":{"direct":true},"balance_after":213346.739,"source":{"system":"sec-edgar","filing":"0001225208-24-005703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005703/doc4.xml","form_type":"4"}},{"id":1538352,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-19T23:07:13.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":5284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Stock Option was granted on April 18, 2024, and one-third of the shares subject to the Stock Option shall vest on April 18, 2025, with one-third of the remaining shares subject to the Stock Option vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":5284,"derivative":{"exercise_price":51.08,"expiration_date":"2034-04-17","underlying":"Common Stock","underlying_shares":5284},"source":{"system":"sec-edgar","filing":"0001628280-24-017007","document":"wk-form4_1713568017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828024017007/wk-form4_1713568017.xml","form_type":"4"}},{"id":1538351,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-19T23:07:13.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":3054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-third of the RSUs shall vest on April 18, 2025, with one-third of the remaining RSUs vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":3054,"source":{"system":"sec-edgar","filing":"0001628280-24-017007","document":"wk-form4_1713568017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1440660/000162828024017007/wk-form4_1713568017.xml","form_type":"4"}},{"id":1639245,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2024-02-16T23:39:53.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":317,"price":86.04,"value":27274.68,"ownership":{"direct":true},"balance_after":213476.7137,"source":{"system":"sec-edgar","filing":"0001225208-24-002344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824002344/doc4.xml","form_type":"4"}},{"id":1713023,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-12-14T00:04:50.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":false,"shares":8658,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":8658},"source":{"system":"sec-edgar","filing":"0001225208-23-011073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011073/doc4.xml","form_type":"4"}},{"id":1713022,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-12-14T00:04:50.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":8658,"price":71.86,"value":622163.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-011073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011073/doc4.xml","form_type":"4"}},{"id":1713021,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-12-14T00:04:50.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":true,"shares":8658,"price":45.2767,"value":392005.6686,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":222451.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-011073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011073/doc4.xml","form_type":"4"}},{"id":1744595,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-11-13T22:21:44.000Z","date":"2023-11-13","kind":"exercise","planned":true,"acquired":false,"shares":8660,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8658,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":8660},"source":{"system":"sec-edgar","filing":"0001225208-23-010211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010211/doc4.xml","form_type":"4"}},{"id":1744594,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-11-13T22:21:44.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":5402,"price":65.6359,"value":354565.1318,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $65.21 to $66.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-010211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010211/doc4.xml","form_type":"4"}},{"id":1744593,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-11-13T22:21:44.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":3158,"price":64.6845,"value":204273.651,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $64.20 to $65.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":219195.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-010211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010211/doc4.xml","form_type":"4"}},{"id":1744592,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-11-13T22:21:44.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":100,"price":66.21,"value":6621.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":222353.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-010211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010211/doc4.xml","form_type":"4"}},{"id":1744591,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-11-13T22:21:44.000Z","date":"2023-11-13","kind":"exercise","planned":true,"acquired":true,"shares":8660,"price":45.2767,"value":392096.222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":222453.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-010211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823010211/doc4.xml","form_type":"4"}},{"id":1760746,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-10-13T21:02:22.000Z","date":"2023-10-13","kind":"exercise","planned":true,"acquired":false,"shares":8660,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17318,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":8660},"source":{"system":"sec-edgar","filing":"0001225208-23-009479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009479/doc4.xml","form_type":"4"}},{"id":1760745,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-10-13T21:02:22.000Z","date":"2023-10-13","kind":"sale","planned":true,"acquired":false,"shares":5150,"price":70.2648,"value":361863.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $70.05 to $70.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-009479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009479/doc4.xml","form_type":"4"}},{"id":1760744,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-10-13T21:02:22.000Z","date":"2023-10-13","kind":"sale","planned":true,"acquired":false,"shares":3510,"price":69.6109,"value":244334.259,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $69.05 to $70.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":218943.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-009479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009479/doc4.xml","form_type":"4"}},{"id":1760743,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-10-13T21:02:22.000Z","date":"2023-10-13","kind":"exercise","planned":true,"acquired":true,"shares":8660,"price":45.2767,"value":392096.222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":222453.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-009479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823009479/doc4.xml","form_type":"4"}},{"id":1781301,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-09-15T00:00:32.000Z","date":"2023-09-14","kind":"exercise","planned":true,"acquired":false,"shares":8660,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25978,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":8660},"source":{"system":"sec-edgar","filing":"0001225208-23-008936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008936/doc4.xml","form_type":"4"}},{"id":1781300,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-09-15T00:00:32.000Z","date":"2023-09-14","kind":"sale","planned":true,"acquired":false,"shares":8660,"price":73.6276,"value":637615.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $73.23 to $73.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-008936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008936/doc4.xml","form_type":"4"}},{"id":1781299,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-09-15T00:00:32.000Z","date":"2023-09-14","kind":"exercise","planned":true,"acquired":true,"shares":8660,"price":45.2767,"value":392096.222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":222453.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-008936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008936/doc4.xml","form_type":"4"}},{"id":1809029,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-08-14T22:02:55.000Z","date":"2023-08-14","kind":"exercise","planned":true,"acquired":false,"shares":6421,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34638,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":6421},"source":{"system":"sec-edgar","filing":"0001225208-23-008219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008219/doc4.xml","form_type":"4"}},{"id":1809028,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-08-14T22:02:55.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":6421,"price":79.3,"value":509185.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-008219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008219/doc4.xml","form_type":"4"}},{"id":1809027,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-08-14T22:02:55.000Z","date":"2023-08-14","kind":"exercise","planned":true,"acquired":true,"shares":6421,"price":45.2767,"value":290721.6907,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":220214.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-008219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823008219/doc4.xml","form_type":"4"}},{"id":1829828,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-07-14T21:58:14.000Z","date":"2023-07-14","kind":"exercise","planned":true,"acquired":false,"shares":8660,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41059,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":8660},"source":{"system":"sec-edgar","filing":"0001225208-23-007511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007511/doc4.xml","form_type":"4"}},{"id":1829827,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-07-14T21:58:14.000Z","date":"2023-07-14","kind":"sale","planned":true,"acquired":false,"shares":8660,"price":92.938,"value":804843.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $92.68 to $93.24 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-007511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007511/doc4.xml","form_type":"4"}},{"id":1829826,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-07-14T21:58:14.000Z","date":"2023-07-14","kind":"exercise","planned":true,"acquired":true,"shares":8660,"price":45.2767,"value":392096.222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":222453.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-007511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007511/doc4.xml","form_type":"4"}},{"id":1856397,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-06-14T20:46:17.000Z","date":"2023-06-14","kind":"exercise","planned":true,"acquired":false,"shares":8660,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49719,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":8660},"source":{"system":"sec-edgar","filing":"0001225208-23-006823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006823/doc4.xml","form_type":"4"}},{"id":1856396,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-06-14T20:46:17.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":5810,"price":89.8713,"value":522152.253,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $89.47 to $90.46 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-006823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006823/doc4.xml","form_type":"4"}},{"id":1856395,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-06-14T20:46:17.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":2850,"price":90.7117,"value":258528.345,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $90.49 to $90.97 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":219603.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-006823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006823/doc4.xml","form_type":"4"}},{"id":1856394,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-06-14T20:46:17.000Z","date":"2023-06-14","kind":"exercise","planned":true,"acquired":true,"shares":8660,"price":45.2767,"value":392096.222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":222453.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-006823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006823/doc4.xml","form_type":"4"}},{"id":1880235,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-05-24T23:19:47.000Z","date":"2023-05-24","kind":"exercise","planned":true,"acquired":false,"shares":6421,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58379,"derivative":{"exercise_price":45.2767,"exercise_date":"2019-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":6421},"source":{"system":"sec-edgar","filing":"0001225208-23-006208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006208/doc4.xml","form_type":"4"}},{"id":1880234,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-05-24T23:19:47.000Z","date":"2023-05-24","kind":"sale","planned":true,"acquired":false,"shares":6421,"price":84.23,"value":540840.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-006208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006208/doc4.xml","form_type":"4"}},{"id":1880233,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-05-24T23:19:47.000Z","date":"2023-05-24","kind":"exercise","planned":true,"acquired":true,"shares":6421,"price":45.2767,"value":290721.6907,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023."}],"balance_after":220214.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-006208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823006208/doc4.xml","form_type":"4"}},{"id":1894042,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Performance Rights","published_at":"2023-05-15T22:26:54.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":9725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":9725,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":9725},"source":{"system":"sec-edgar","filing":"0001225208-23-005919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005919/doc4.xml","form_type":"4"}},{"id":1894041,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-05-15T22:26:54.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":65700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":65700,"derivative":{"exercise_price":88.78,"exercise_date":"2024-05-11","expiration_date":"2030-05-10","underlying":"Common Stock","underlying_shares":65700},"source":{"system":"sec-edgar","filing":"0001225208-23-005919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005919/doc4.xml","form_type":"4"}},{"id":1894040,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"Global President TAVR & Surg"}}],"security":"Common Stock","published_at":"2023-05-15T22:26:54.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects shares transferred to the reporting person's ex-spouse pursuant to a divorce judgement. The securities owned by the ex-spouse are not beneficially owned by the reporting person."}],"balance_after":213793.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-005919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005919/doc4.xml","form_type":"4"}},{"id":1899925,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP & Grp President TAVR & SSH"}}],"security":"Performance Rights","published_at":"2023-05-09T23:50:05.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":false,"shares":5415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":1485,"derivative":{"exercise_date":"2023-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":5415},"source":{"system":"sec-edgar","filing":"0001225208-23-005620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005620/doc4.xml","form_type":"4"}},{"id":1899924,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP & Grp President TAVR & SSH"}}],"security":"Common Stock","published_at":"2023-05-09T23:50:05.000Z","date":"2023-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1472,"price":88.74,"value":130625.28,"ownership":{"direct":true},"balance_after":206310.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-005620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005620/doc4.xml","form_type":"4"}},{"id":1899923,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP & Grp President TAVR & SSH"}}],"security":"Common Stock","published_at":"2023-05-09T23:50:05.000Z","date":"2023-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2583,"price":88.74,"value":229215.42,"ownership":{"direct":true},"balance_after":207782.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-005620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005620/doc4.xml","form_type":"4"}},{"id":1899922,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP & Grp President TAVR & SSH"}}],"security":"Common Stock","published_at":"2023-05-09T23:50:05.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":true,"shares":5415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":210365.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-005620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005620/doc4.xml","form_type":"4"}},{"id":1904799,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP & Grp President TAVR & SSH"}}],"security":"Common Stock","published_at":"2023-05-05T01:49:50.000Z","date":"2023-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":396,"price":88.1,"value":34887.6,"ownership":{"direct":true},"balance_after":204950.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-005435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005435/doc4.xml","form_type":"4"}},{"id":1904798,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP & Grp President TAVR & SSH"}}],"security":"Common Stock","published_at":"2023-05-05T01:49:50.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":383,"price":87.81,"value":33631.23,"ownership":{"direct":true},"balance_after":205346.7137,"source":{"system":"sec-edgar","filing":"0001225208-23-005435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005435/doc4.xml","form_type":"4"}},{"id":2008822,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP & Grp President TAVR & SSH"}}],"security":"Common Stock","published_at":"2023-02-17T23:35:10.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":3235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on February 16, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":205466.8049,"source":{"system":"sec-edgar","filing":"0001225208-23-002276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823002276/doc4.xml","form_type":"4"}},{"id":2088609,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-12-13T22:29:02.000Z","date":"2022-12-13","kind":"exercise","acquired":false,"shares":7236,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7236},"source":{"system":"sec-edgar","filing":"0001225208-22-012623","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012623/doc4.xml","form_type":"4"}},{"id":2088608,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-12-13T22:29:02.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":6936,"price":76.9567,"value":533771.6712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $76.43 to $77.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":202231.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-012623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012623/doc4.xml","form_type":"4"}},{"id":2088607,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-12-13T22:29:02.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":300,"price":77.4833,"value":23244.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.43 to $77.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":209167.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-012623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012623/doc4.xml","form_type":"4"}},{"id":2088606,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-12-13T22:29:02.000Z","date":"2022-12-13","kind":"exercise","acquired":true,"shares":7236,"price":36.75,"value":265923.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."}],"balance_after":209467.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-012623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822012623/doc4.xml","form_type":"4"}},{"id":2122582,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-11-08T23:01:25.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7236,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001225208-22-011465","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822011465/doc4.xml","form_type":"4"}},{"id":2122581,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-11-08T23:01:25.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":7242,"price":68.4983,"value":496064.6886,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $68.195 to $68.595. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":202231.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-011465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822011465/doc4.xml","form_type":"4"}},{"id":2122580,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-11-08T23:01:25.000Z","date":"2022-11-08","kind":"exercise","acquired":true,"shares":7242,"price":36.75,"value":266143.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."}],"balance_after":209473.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-011465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822011465/doc4.xml","form_type":"4"}},{"id":2139564,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-10-11T22:22:25.000Z","date":"2022-10-11","kind":"exercise","acquired":false,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14478,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001225208-22-010943","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010943/doc4.xml","form_type":"4"}},{"id":2139563,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-10-11T22:22:25.000Z","date":"2022-10-11","kind":"sale","acquired":false,"shares":7242,"price":82.12,"value":594713.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."}],"balance_after":202231.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-010943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010943/doc4.xml","form_type":"4"}},{"id":2139562,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-10-11T22:22:25.000Z","date":"2022-10-11","kind":"exercise","acquired":true,"shares":7242,"price":36.75,"value":266143.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."}],"balance_after":209473.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-010943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010943/doc4.xml","form_type":"4"}},{"id":2166392,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-09-06T22:40:15.000Z","date":"2022-09-06","kind":"exercise","acquired":false,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21720,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001225208-22-010085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010085/doc4.xml","form_type":"4"}},{"id":2166391,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-09-06T22:40:15.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":7242,"price":89,"value":644538.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."}],"balance_after":202231.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-010085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010085/doc4.xml","form_type":"4"}},{"id":2166390,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-09-06T22:40:15.000Z","date":"2022-09-06","kind":"exercise","acquired":true,"shares":7242,"price":36.75,"value":266143.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."}],"balance_after":209473.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-010085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822010085/doc4.xml","form_type":"4"}},{"id":2191314,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-08-09T22:16:06.000Z","date":"2022-08-09","kind":"exercise","acquired":false,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28962,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001225208-22-009403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822009403/doc4.xml","form_type":"4"}},{"id":2191313,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-08-09T22:16:06.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":5324,"price":104.5937,"value":556856.8588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $104.01 to $104.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":202231.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-009403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822009403/doc4.xml","form_type":"4"}},{"id":2191312,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-08-09T22:16:06.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":1918,"price":105.0298,"value":201447.1564,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $105.01 to $105.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":207555.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-009403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822009403/doc4.xml","form_type":"4"}},{"id":2191311,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-08-09T22:16:06.000Z","date":"2022-08-09","kind":"exercise","acquired":true,"shares":7242,"price":36.75,"value":266143.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."}],"balance_after":209473.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-009403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822009403/doc4.xml","form_type":"4"}},{"id":2215534,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-07-06T00:59:17.000Z","date":"2022-07-05","kind":"exercise","acquired":false,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36204,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001225208-22-008534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008534/doc4.xml","form_type":"4"}},{"id":2215533,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-07-06T00:59:17.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":7242,"price":95.897,"value":694486.074,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $95.205 to $95.910. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":202231.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-008534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008534/doc4.xml","form_type":"4"}},{"id":2215532,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-07-06T00:59:17.000Z","date":"2022-07-05","kind":"exercise","acquired":true,"shares":7242,"price":36.75,"value":266143.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."}],"balance_after":209473.8049,"source":{"system":"sec-edgar","filing":"0001225208-22-008534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008534/doc4.xml","form_type":"4"}},{"id":2250024,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-06-01T22:04:41.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43446,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001225208-22-007557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007557/doc4.xml","form_type":"4"}},{"id":2250023,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-06-01T22:04:41.000Z","date":"2022-06-01","kind":"sale","acquired":false,"shares":4479,"price":100.187,"value":448737.573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $99.76 to $100.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":202199.0338,"source":{"system":"sec-edgar","filing":"0001225208-22-007557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007557/doc4.xml","form_type":"4"}},{"id":2250022,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-06-01T22:04:41.000Z","date":"2022-06-01","kind":"sale","acquired":false,"shares":2763,"price":101.0913,"value":279315.2619,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $100.78 to $101.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":206678.0338,"source":{"system":"sec-edgar","filing":"0001225208-22-007557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007557/doc4.xml","form_type":"4"}},{"id":2250021,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-06-01T22:04:41.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":7242,"price":36.75,"value":266143.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares transferred to the reporting person's ex-spouse pursuant to a divorce judgement. The securities owned by the ex-spouse are not beneficially owned by the reporting person."}],"balance_after":209441.0338,"source":{"system":"sec-edgar","filing":"0001225208-22-007557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007557/doc4.xml","form_type":"4"}},{"id":2268870,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2022-05-18T01:16:43.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":1816,"price":95.93,"value":174208.88,"ownership":{"direct":true},"balance_after":204253.0338,"source":{"system":"sec-edgar","filing":"0001225208-22-007139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007139/doc4.xml","form_type":"4"}},{"id":2276616,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24987,"kind":"person","name":"Wood Larry L","position":1,"cik":"0001440660","reported_name":"Wood Larry L","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-05-11T00:54:47.000Z","date":"2022-05-10","kind":"exercise","acquired":false,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50688,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001225208-22-006817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006817/doc4.xml","form_type":"4"}}],"next_cursor":"2022-05-11T00:54:47.000000Z,2276616"}